{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:03:36Z","timestamp":1793293416746,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jaad.2015.02.1113","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T16:16:41Z","timestamp":1431101801000},"page":"1036-1046.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma"],"prefix":"10.1016","volume":"72","author":[{"given":"Soo Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Nyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Jin","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Beom","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Joong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.02.1113_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.02.1113_bib2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.02.1113_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.02.1113_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicenter, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2015.02.1113_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2015.02.1113_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0022-202X.2004.22722.x","article-title":"BRAF point mutations in primary melanoma show different prevalences by subtype","volume":"123","author":"Sasaki","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.0022-202X.2005.23833.x","article-title":"Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes","volume":"125","author":"Lang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting; meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2015.02.1113_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2015.02.1113_bib10","series-title":"Systematic reviews in health-care: meta-analysis in context","author":"Egger","year":"2001"},{"key":"10.1016\/j.jaad.2015.02.1113_bib11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jaad.2015.02.1113_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000372-200310000-00001","article-title":"BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin","volume":"25","author":"Uribe","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib13","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2015.02.1113_bib14","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.11722","article-title":"Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas","volume":"109","author":"Reifenberger","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.02.1113_bib16","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/1078-0432.CCR-1169-3","article-title":"Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas","volume":"10","author":"Shinozaki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.0022-202X.2004.22523.x","article-title":"Tandem BRAF mutations in primary invasive melanomas","volume":"122","author":"Thomas","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000079490","article-title":"B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome","volume":"66","author":"Deichmann","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.jaad.2015.02.1113_bib19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/cc.4.10.2026","article-title":"Analysis of BRAF mutation in primary and metastatic melanoma","volume":"4","author":"Libra","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jaad.2015.02.1113_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.0022-202X.2005.23788.x","article-title":"BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival","volume":"125","author":"Akslen","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0022-202X.2005.23812.x","article-title":"Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas","volume":"125","author":"Takata","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib22","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.02.1113_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700026","article-title":"Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma","volume":"126","author":"Goel","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib24","first-page":"139","article-title":"The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites","volume":"29","author":"Deichmann","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.cmr.0000222600.73179.f3","article-title":"BRAF and NRAS mutations in melanoma and melanocytic nevi","volume":"16","author":"Poynter","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib26","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","article-title":"Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies","volume":"12","author":"Saldanha","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.jid.5700632","article-title":"Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma","volume":"127","author":"Liu","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1055-9965.EPI-06-1038","article-title":"Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma","volume":"16","author":"Thomas","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2015.02.1113_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CMR.0b013e3282f32517","article-title":"Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma","volume":"18","author":"Akslen","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib31","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/jid.2008.67","article-title":"MC1R variants increase risk of melanomas harboring BRAF mutations","volume":"128","author":"Fargnoli","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib32","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.jaad.2015.02.1113_bib33","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"1","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molonc.2008.01.002","article-title":"Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas","volume":"1","author":"Kannengiesser","year":"2008","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2008.08887.x","article-title":"RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis","volume":"160","author":"Dadzie","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/jid.2008.422","article-title":"Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT","volume":"129","author":"Daniotti","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/DAD.0b013e318185d205","article-title":"Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas","volume":"31","author":"Uribe","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2009.109","article-title":"Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma","volume":"22","author":"L\u00e1z\u00e1r","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jid.2009.182","article-title":"The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population","volume":"130","author":"Hacker","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1755-148X.2010.00778.x","article-title":"Genetic and morphologic features for melanoma classification","volume":"23","author":"Broekaert","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1078-0432.CCR-10-2276","article-title":"Clinical correlates of NRAS and BRAF mutations in primary human melanoma","volume":"17","author":"Ellerhorst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-148X.2011.00837.x","article-title":"BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site","volume":"24","author":"Bauer","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/jid.2010.405","article-title":"BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han","volume":"131","author":"Qi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1755-148X.2011.00873.x","article-title":"Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma","volume":"24","author":"Devitt","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2015.02.1113_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2012.03.005","article-title":"Assessment of BRAF and KIT mutations in Japanese melanoma patients","volume":"66","author":"Ashida","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2015.02.1113_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4132\/KoreanJPathol.2012.46.3.246","article-title":"Frequency of BRAF mutation and clinical relevance for primary melanomas","volume":"46","author":"Lee","year":"2012","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2012.338","article-title":"BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas","volume":"133","author":"Jin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/modpathol.2012.168","article-title":"Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma","volume":"26","author":"Feller","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/jid.2012.385","article-title":"NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations","volume":"133","author":"Hacker","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","article-title":"Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma","volume":"15","author":"Greaves","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jaad.2015.02.1113_bib52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pcmr.12129","article-title":"Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral\/mucosal melanomas","volume":"26","author":"Niu","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/CMR.0b013e32836477d4","article-title":"BRAF and KIT somatic mutations are present in amelanotic melanoma","volume":"23","author":"Massi","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2015.02.1113_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jdermsci.2013.07.013","article-title":"KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma","volume":"72","author":"Zebary","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2015.02.1113_bib55","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib56","doi-asserted-by":"crossref","first-page":"210S","DOI":"10.1038\/jid.1989.67","article-title":"Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan","volume":"92","author":"Kukita","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1113_bib57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/418934a","article-title":"Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status","volume":"418","author":"Rajagopalan","year":"2002","journal-title":"Nature"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215013535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215013535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:34:04Z","timestamp":1759271644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215013535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0190962215013535"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1113","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}